4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.93
+0.47 (5.56%)
At close: Mar 4, 2026, 4:00 PM EST
8.88
-0.05 (-0.56%)
After-hours: Mar 4, 2026, 6:02 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $455.5 million as of March 4, 2026. Its market cap has increased by 103.16% in one year.
Market Cap
455.50M
Enterprise Value
105.54M
1-Year Change
103.16%
Ranking
Category
Stock Price
$8.93
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $455.50M, a decrease of -21.52%. That is a compound annual growth rate of -4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 455.50M | 6.30% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 498.56M |
| Kyverna Therapeutics | 486.46M |
| Invivyd | 485.02M |
| Solid Biosciences | 483.04M |
| Vanda Pharmaceuticals | 482.91M |
| Lineage Cell Therapeutics | 472.54M |
| Tenax Therapeutics | 471.43M |
| Assembly Biosciences | 469.45M |